The leading cause of death in the U.S. is shifting from heart disease to cancer at varying paces across the country, according to Stanford research.
In this final piece in the Understanding AFib series, physician Randall Stafford offers evidence-based advice for remaining healthy with the condition.
In this sixth piece in the Understanding AFib series, physician Randall Stafford explains how medications, procedures and pacemakers can be used for AFib.
A team of Stanford researchers has designed a new flexible "micropillar" electrode to study the behavior of heart cells without affecting their behavior.
In the fifth installment in the Understanding AFib series, Randall Stafford explains how to measure your heart rate and pay attention to your heart rhythm.
A team of Stanford Biodesign innovators has developed a video to increase awareness in India of a serious heart condition, RHD.
In this fourth post in the Understanding AFib series, physician Randall Stafford explains different drugs that are used to slow down the heart.
In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
In the second piece in a the Understanding AFib series, physician Randall Stafford examines which patients should use blood thinners.
In the first of a series on atrial fibrillation, physician Randall Stafford explains the condition and how it increases the risk of stroke.
Scientists have developed an algorithm that combines genome sequence data and electronic health information to predict risk for genetic disease.
John Farquhar, a beloved mentor, and pioneer in cardiovascular disease prevention at Stanford, died Aug. 22 at the age of 91.
Heart muscle cells from people with cardiomyopathies have shorter-than-normal telomeres -- the protective caps on chromosomes associated with aging.
For the past four years cardiologist Josh Knowles, MD, PhD, has been treating patients at Stanford who have a little-known but common genetic heart disease called …
Hypertrophic cardiomyopathy is caused by various genetic mutations that cause heart muscle to contract with too much force. New research suggests why.
This Stars of Stanford Medicine Q&A features Andrew Chang, clinical instructor of medicine, who is working to improve cardiovascular health globally.